Navigation Links
Ranbaxy to Market Desvenlafaxine Base Extended Release Tablets in the U.S.
Date:3/5/2013

p>About Ranbaxy Laboratories Limited
Ranbaxy Laboratories Limited, India's largest pharmaceutical company, is an integrated, research based, international pharmaceutical company producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. Ranbaxy's continued focus on R&D has resulted in several approvals, in developed and emerging markets many of which incorporate proprietary Novel Drug Delivery Systems (NDDS) and technologies, developed at its own labs. The company has further strengthened its focus on generics research and is increasingly working on more complex and specialty areas. Ranbaxy serves its customers in over 150 countries and has an expanding international portfolio of affiliates, joint ventures and alliances, ground operations in 43 countries and manufacturing operations in 8 countries. Ranbaxy is a member of the Daiichi Sankyo Group. Through strategic in-licensing opportunities and its hybrid business model with Daiichi Sankyo, a leading global pharma innovator headquartered in Tokyo, Japan, Ranbaxy is introducing many innovator products in markets around the world, where it has a strong presence. This is in line with the company's commitment to increase penetration and improve access to medicines, across the globe. For more information, please visit www.ranbaxy.com

About Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited, a vertically integrated research and development pharmaceutical company, has been at the forefront of healthcare since 1907. Headquartered in India, Alembic is a publicly listed company that manufactures and markets generic pharmaceutical products all over the world. Alembic's state of the art research and manufacturing facilities are approved by regulatory authorities all over the world including the US FDA. Alembic
'/>"/>

SOURCE Ranbaxy Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Ranbaxy Announces U.S. FDA Approval of CIP-Isotretinoin NDA
2. Ranbaxy Commends New IMS Study Which Credits Generic Prescription Drugs With $1 Trillion Savings In U.S. Health Care Costs Over Past 10 Years
3. Ranbaxy Launches Authorized Generic Of Pioglitazone In The U.S.
4. Ranbaxy Issues Voluntary Nationwide Recall of 41 lots of Atorvastatin Calcium Tablets 10 mg, 20 mg and 40 mg Due to Potential Presence of Foreign Substance
5. Rapid Fire Marketing Funds Development of Second Generation Vapor Inhaler
6. ulrich medical USA™ Releases New Expandable Spinal Implant for US Market
7. Nektar to Announce Financial Results for the First Quarter of 2012 on Wednesday, May 2, 2012, After Close of U.S.-Based Financial Markets
8. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
9. International Drug & Explosives Detection Company IDenta Corp. Releases Information to OTC markets.
10. Althea Technologies Appoints Dr. Kristin DeFife, Director, Biologics Manufacturing And Jack Wright, VP, Sales and Marketing
11. Ophthalmic Drugs: World Market Prospects 2012-2022
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... 2, 2015 China Biologic Products, Inc. ... leading fully integrated plasma-based biopharmaceutical company in ... Company,s subsidiary Guizhou Taibang Biological Products Co., Ltd. ... (the "Agreement") with Xinjiang Deyuan Bioengineering Co., Ltd. ... allows Guizhou Taibang to source no less than ...
(Date:9/2/2015)... , Sept. 2, 2015 Relmada Therapeutics, ... therapies for the treatment of chronic pain, announced today ... at both the FBR Second Annual Healthcare Conference and ... follows: FBR Second Annual Healthcare Conference ... Boston No presentation, investor meetings ...
(Date:9/2/2015)... , Sept. 2, 2015  Kastle Therapeutics (Kastle), ... commercializing pharmaceuticals for diseases with high unmet medical ... executives to key commercial operating positions. ... President, Commercial; Sean was previously Global Marketing Director ... appointed as Director, Commercial Strategy and Analytics; Nick ...
Breaking Medicine Technology:China Biologic Enters into Strategic Collaboration Agreement to Source Raw Materials 2China Biologic Enters into Strategic Collaboration Agreement to Source Raw Materials 3China Biologic Enters into Strategic Collaboration Agreement to Source Raw Materials 4China Biologic Enters into Strategic Collaboration Agreement to Source Raw Materials 5Relmada Therapeutics to Participate in Two Upcoming Investor Conferences 2Kastle Therapeutics Announces Key Additions to Commercial Leadership 2Kastle Therapeutics Announces Key Additions to Commercial Leadership 3
...  ChromaDex® Corporation (OTCBB: CDXC), an innovative natural products ... to the dietary supplement, food & beverage, cosmetic ... and unit sales of its recently launched ... the Company,s initial forecast and expectations during the ...
... May 16, 2012  Inrad Optics, Inc. (OTCBB: INRD) has released its ... 2012. Revenues for the first quarter were ... period last year. Orders for the first three ... Order backlog increased to $5.2 million for the three months ...
Cached Medicine Technology:ChromaDex® Experiencing Higher Than Expected Demand For Its Recently Launched BluScience™ Line of Dietary Supplements 2ChromaDex® Experiencing Higher Than Expected Demand For Its Recently Launched BluScience™ Line of Dietary Supplements 3ChromaDex® Experiencing Higher Than Expected Demand For Its Recently Launched BluScience™ Line of Dietary Supplements 4ChromaDex® Experiencing Higher Than Expected Demand For Its Recently Launched BluScience™ Line of Dietary Supplements 5Inrad Optics, Inc. Announces Financial Results For First Quarter 2012 2Inrad Optics, Inc. Announces Financial Results For First Quarter 2012 3Inrad Optics, Inc. Announces Financial Results For First Quarter 2012 4Inrad Optics, Inc. Announces Financial Results For First Quarter 2012 5Inrad Optics, Inc. Announces Financial Results For First Quarter 2012 6
(Date:9/2/2015)... ... September 02, 2015 , ... ... content, records and case management solutions and services to both government and commercial ... Re-sizing and Image Clean-up utility for IBM’s Datacap document capture platform. EDAC ...
(Date:9/2/2015)... ... September 02, 2015 , ... Available ... marine cosmetics introduces PIONNIÈRE XMF Perfection Youth Rich Cream , an evolution ... biotechnological anti-aging power with a lipid-replenishing marine oil for intense nourishing and moisturizing. ...
(Date:9/2/2015)... ... September 02, 2015 , ... Dr. Robert G. Schwartz , ... now certified in “Systema”: a Russian martial art system that is also a philosophy ... Systema , which dates back to the 10th century, is a Russian Martial ...
(Date:9/1/2015)... ... September 01, 2015 , ... An August 25 ... plastic surgeries conducted each year on teenagers, quoting a New York City-area plastic ... Hills-based plastic surgeon Payam Jarrah-Nejad, M.D., F.I.C.S., F.A.C.S., known more familiarly to patients ...
(Date:9/1/2015)... ... September 02, 2015 , ... The Journal of Pain Research ... in the USA ”. , As corresponding author Mr Christopher Malone says “Migraine headache ... our study, we endeavoured to better understand how migraine headaches impact the lives of ...
Breaking Medicine News(10 mins):Health News:EDAC Systems, Inc. announces a new version of its Image Enhancement and Image Re-Sizing utility EDAC’s PurePAGE® 2Health News:EDAC Systems, Inc. announces a new version of its Image Enhancement and Image Re-Sizing utility EDAC’s PurePAGE® 3Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 2Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 3Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 4Health News:Dr. Robert G. Schwartz Achieves Certification in Russian Martial Art “Systema” and Focuses on Integrating Techniques & Principles into Health Care Delivery 2Health News:Dr. Robert G. Schwartz Achieves Certification in Russian Martial Art “Systema” and Focuses on Integrating Techniques & Principles into Health Care Delivery 3Health News:Teen Plastic Surgery Article Understates the Most Important Realities of Procedures on Young People, Notes Dr. J 2Health News:Migraine, treatment, comorbidities, and quality of life published by Dove Medical Press 2
... France June 04, 2009 The cause of ... after Alzheimer,s disease, is unknown, but in most cases ... risk factors and genetic susceptibility. Laboratory studies in rats ... an animal model of PD and several epidemiological studies ...
... BioTrends Research Group, Inc. announces the release of the baseline ... The survey was completed by U.S. Rheumatologists in May 2009, ... , Once monthly dosing seems to be playing well, according ... of SIMPONI. 84% of the Rheumatologists surveyed report that they ...
... Pa., June 4 Herley Industries, Inc. (Nasdaq: ... Israel, has recently received contracts valued at approximately $4 million ... customer. These are follow-on awards for an existing customer ... to a U.S. aircraft. , , Herley Industries, Inc. ...
... The Cardiovascular Nurse and Technologist Symposium at TCT 2009 ... clinical/administrative strategies for the management of the cardiovascular patient: ... receiving PCI, Revascularization decisions, Management decisions regarding patients with ... charge of your own health WHEN: ...
... uninterrupted supply for customers , , LAKE ZURICH, Ill., ... improving blood collection, safety and availability for patient care, said ... a patent lawsuit brought by Haemonetics Corporation in 2005. ... , , In conjunction with this litigation, ...
... , For Father,s Day, Forget The Usual With A Gift ... Physician Formulated Anti-Wrinkle Moisturizer , , PACIFIC PALISADES, Calif., ... This year, give Dad something he secretly desires but may ... the best for the family hero. Dermagenics Physician-Formulated ...
Cached Medicine News:Health News:Association found between Parkinson's disease and pesticide exposure in French farm workers 2Health News:Once Monthly Dosing: How Much of a Competitive Advantage is it? Rheumatologists Provide Insight in the Baseline Report of LaunchTrends(TM): SIMPONI(TM) 2Health News:Herley's Israeli Subsidiary, GMI Eyal, is Selected to Provide Complex Microwave Switch Assemblies for a U.S. Customer 2Health News:Nurses: Providing angioplasty patient care in and out of the cath lab 2Health News:Fenwal Statement Regarding Patent Litigation 2Health News:SHOW DAD YOU LOVE HIS FACE 2
... The VersaPulse PowerSuite holmium laser ... properties for precise, virtually bloodless procedures. ... fragmenting urinary and gall bladder stones ... ideal multipurpose surgical tool. Because its ...
... Nd:YAG technology has allowed for perfecting mini-invasive ... of various pathologies with a considerable social ... for reducing the post-operatory times and represents ... costs in all hospital structures.,DEKAs family of ...
... have to choose. The Apogee Elite ... 755nm Alexandrite laser and a high ... in one convenient unit. The ... for hair removal, pigmented lesions, facial ...
Single use trocar with non-conductive sleeves for gaining and maintaining thoracic access., ,THORACOPORT™ devices are trocars used to gain access to the thoracic cavity for use in video assis...
Medicine Products: